Coronavirus disease 2019 (COVID-19) pandemic has brought challenges to health and social care systems. However, the empirical use…
The aim of our study was to evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in Mexico…
Bacterial coinfection is associated with poor outcomes in patients with viral pneumonia, but data on its role in…
This article highlights the administration of antimicrobials in COVID-19 patients worldwide, during the 2019–20 pandemic. It is imperative…
In patients with severe or critical covid-19, tocilizumab plus standard care was not superior to standard care alone…
Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered…
SARS-CoV-2 infection is a multisystem disease with post-discharge sequelae. We report early follow-up data from one UK hospital…
Shekerdemian et al 1 reported 48 coronavirus disease 2019–positive children (median age, 13 years) admitted to pediatric intensive…
This guidance adds to recommendations for corticosteroids and remdesivir published in the previous versions, with no changes made…
Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of…
Recent data suggest that complications and death from coronavirus disease 2019 (Covid-19) may be related to high viral…
World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and…
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status…
The novel coronavirus disease 2019 (COVID-19) is a global pandemic that continues to sweep across the world, posing…
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation…
Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of…
The race to identify a successful treatment for COVID19 will be defined by fundamental research into the replication…
There is currently no treatment known to alter the course of coronavirus disease 2019 (COVID-19). Convalescent plasma has…
Ivermectin exerts broad-spectrum antiviral activity against several animal and human viruses, including both RNA and DNA viruses. As…